Mast Cell Activation Syndrome: The Hidden Trigger Behind Your Unexplained Symptoms

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Mast Cell Activation Syndrome (MCAS) is a condition in which mast cells—immune cells involved in inflammation and allergic responses—release excessive or inappropriate chemical mediators such as histamine, prostaglandins, and cytokines. This dysregulated immune signalling may contribute to chronic, multisystem symptoms including fatigue, brain fog, digestive issues, skin reactions, and anxiety, often despite “normal” standard medical tests.

MCAS is a clinical diagnosis of exclusion, based on recognised criteria that include typical symptom patterns across multiple organ systems, evidence of mast cell mediator involvement, and exclusion of alternative diagnoses. Laboratory markers are supportive rather than definitive, and no single test can confirm or rule out MCAS in isolation.

Understanding Mast Cells: The Body’s First Responders Gone Rogue

Mast cells are specialised immune cells found throughout connective tissue, including the skin, lungs, gastrointestinal tract, and blood vessels. Their role is to detect potential threats—such as pathogens or allergens—and release inflammatory mediators that coordinate immune defence.

In MCAS, mast cells become hyper-responsive, releasing mediators too frequently, in excessive amounts, or in response to non-threatening stimuli such as foods, temperature changes, fragrances, or psychological stress. Rather than resolving inflammation, this ongoing activation may drive persistent, system-wide symptoms.

The Overlooked Connection: When Symptoms Don’t Fit the Textbook

Because mast cells are present in nearly every tissue, mast cell activation can affect multiple organ systems at once. Clinical presentations vary widely between individuals, which contributes to under-recognition.

Commonly reported symptoms include:

Neurological & Cognitive

• Fatigue
• Cognitive impairment (“brain fog”)
• Headaches
• Dizziness
• Sleep disturbance

Gastrointestinal

• Bloating
• Diarrhoea
• Nausea
• Food sensitivities

Skin & Respiratory

• Flushing
• Itching
• Hives
• Unexplained rashes
• Nasal congestion
• Non–IgE mediated allergic-type reactions

Cardiovascular & Autonomic

• Palpitations
• Light-headedness
• Low blood pressure

Psychological

• Anxiety
• Irritability

When symptoms are evaluated in isolation, the underlying immune pattern may be missed.

Why Conventional Medicine Often Misses Mast Cell Activation Syndrome

1. Lack of Definitive Testing

There is no single diagnostic blood test for MCAS. Markers such as serum tryptase, histamine, or prostaglandins fluctuate and may appear normal between symptom flares. As a result, testing performed outside of active episodes can be falsely reassuring.

2. Symptom Overlap

MCAS may coexist with or resemble conditions such as irritable bowel syndrome (IBS), eczema, asthma, postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndromes, and anxiety disorders. These overlaps often lead to multiple partial diagnoses rather than identification of a shared immune driver.

3. Single-System Focus

Conventional care typically evaluates organs in isolation. Mast cells, however, act as cross-system communicators, interacting with the immune, nervous, endocrine, and gastrointestinal systems simultaneously.

4. Emerging Role in Post-Viral Syndromes

Mast cell activation has been observed in association with Long COVID and other post-viral inflammatory states, where persistent immune activation overlaps with mechanisms commonly seen in post-viral fatigue presentations, although clinical awareness and training remain variable.

How MCAS Can Affect the Body

Brain and Nervous System

Histamine and inflammatory cytokines released by mast cells can influence neurotransmission and autonomic function. This may contribute to headaches, dizziness, anxiety, cognitive dysfunction, palpitations, and light-headedness.

Digestive System

Within the gut, mast cells regulate motility and intestinal permeability. When over-activated, they may increase gut sensitivity, leading to bloating, abdominal pain, diarrhoea, and reactions to foods that were previously well tolerated. These patterns frequently overlap with underlying gut microbiome imbalances and immune–gut signalling disturbances.

Skin and Respiratory System

Cutaneous flushing, hives, or itching may occur without identifiable allergens. Respiratory symptoms triggered by fragrances or environmental exposures may reflect mast cell hyper-reactivity rather than classical allergy.

Hormonal and Immune Interactions

Histamine interacts with oestrogen metabolism, and mast cells respond to hormonal signals. Some individuals notice symptom flares around menstrual cycles, perimenopause, or periods of sustained physiological stress.

Why Mast Cells Become Overactive

MCAS rarely develops in isolation. Contributing factors may include:

• Chronic or post-infectious immune activation
• Gut dysbiosis and increased intestinal permeability
• Environmental exposures such as mould or toxins
• High dietary histamine load
• Nutrient insufficiencies
• Hormonal transitions and chronic stress

Over time, these inputs can prime mast cells toward persistent activation rather than appropriate resolution.

How Comprehensive Testing Can Reveal Patterns

1. Diagnostic and Exclusionary Considerations

Formal diagnostic frameworks describe MCAS as a clinical syndrome requiring recurrent multisystem symptoms consistent with mast cell mediator release, evidence of mast cell involvement, and exclusion of alternative diagnoses such as clonal mast cell disease or primary allergic disorders.

2. Supportive Pathology Markers (Not Diagnostic Alone)

Markers such as serum tryptase, histamine activity, inflammatory markers, full blood count, and nutrient status may provide supportive context but cannot independently confirm or exclude MCAS.

3. Genetic and Methylation Considerations

Genetic variants such as MTHFR, COMT, or DAO may influence histamine clearance or detoxification efficiency. These variants do not cause MCAS, but may modify symptom expression and nutrient requirements through effects on methylation pathways.

The Role of Methylation and Nutrients

Methylation is a biochemical process involved in detoxification, neurotransmitter balance, and histamine clearance. Suboptimal methylation—due to nutrient insufficiency or genetic variation—may exacerbate histamine accumulation in susceptible individuals. Targeted support should always be guided by testing, as poorly matched supplementation can worsen symptoms in some cases.

A Multi-Layered Management Approach

Management of MCAS focuses on reducing triggers and stabilising immune signalling rather than suppressing symptoms alone. Responses vary significantly between individuals, reinforcing the need for personalised assessment.

Finding Clarity Through Personalised Assessment

For individuals with persistent, unexplained symptoms and normal standard investigations, mast cell activation may provide a unifying explanatory framework rather than a new label. Functional and nutritional medicine approaches aim to map immune, gut, and hormonal interactions to guide personalised care.

References

1. Akin C. Mast cell activation disorders. J Allergy Clin Immunol. 2017.
2. Valent P et al. Mast cell activation syndromes: definition and classification. Allergy. 2012.
3. Afrin LB et al. Diagnosis of mast cell activation syndrome. Immunol Allergy Clin North Am. 2014.
4. Theoharides TC et al. Mast cells and inflammation. Biochim Biophys Acta. 2012.
5. Weinstock LB et al. Mast cell activation syndrome and the GI tract. Gastroenterol Hepatol. 2021.
6. Butterfield JH. Survey of mediator levels in MCAS. J Allergy Clin Immunol Pract. 2020.
7. Kritas SK et al. Mast cells and the brain. Int J Immunopathol Pharmacol. 2013.
8. Theoharides TC. Neuroinflammation and mast cells. Front Cell Neurosci. 2018.
9. Afrin LB et al. POTS, EDS, and MCAS overlap. Auton Neurosci. 2017.
10. Galli SJ et al. Mast cells in immunity. Nature. 2008.
11. Weinstock LB et al. IBS and mast cell activation. Neurogastroenterol Motil. 2018.
12. Theoharides TC et al. Mast cells and COVID-19. Clin Ther. 2020.
13. Conti P et al. Mast cell activation in post-viral syndromes. J Biol Regul Homeost Agents. 2021.
14. Maintz L, Novak N. Histamine intolerance. Am J Clin Nutr. 2007.
15. Comas-Basté O et al. DAO and histamine metabolism. Nutrients. 2020.
16. O’Sullivan BP et al. Methylation and immune regulation. Clin Epigenetics. 2018.
17. Liu T et al. Quercetin and mast cell stabilisation. Inflamm Res. 2018.
18. Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017.
19. Gröber U et al. Magnesium in inflammation. Nutrients. 2015.
20. Valent P. Diagnostic criteria for MCAS. Allergy. 2019.